Our mission is to become a worldwide reference for education in the field for all professionals involved in the process to dissemintate knowledge & skills of Acute Cardiovascular Care
Our mission is to promote excellence in clinical diagnosis, research, technical development, and education in cardiovascular imaging in Europe.
Our mission: To promote excellence in research, practice, education and policy in cardiovascular health, primary and secondary prevention.
Our goal is to reduce the burden in cardiovascular disease in Europe through percutaneous cardiovascular interventions.
Our Mission is "to improve the quality of life of the population by reducing the impact of cardiac rhythm disturbances and reduce sudden cardiac death"
To improve quality of life and logevity, through better prevention, diagnosis and treatment of heart failure, including the establishment of networks for its management, education and research.
Working Groups goals is to stimulate and disseminate scientific knowledge in different fields of cardiology.
ESC Councils goal is to share knowledge among medical professionals practising in specific cardiology domains.
OUR MISSION: TO REDUCE THE BURDEN OF CARDIOVASCULAR DISEASE
Dr. Matthias G Friedrich
More than 120 ESC participants attended the session on myocardial oedema as a novel diagnostic target in acute heart disease. Recent studies using Cardiovascular Magnetic Resonance (CMR) to non-invasively detect and quantify the extent of myocardial oedema in acute myocardial infarction and acute myocarditis have raised huge interest in the cardiology community. The chairs, Håkan Arheden and Matthias Friedrich welcomed an impressive international speaker panel. Dr. Anthony Aletras set the stage by discussing the pathophysiology of myocardial oedema and the different available diagnostic approaches, concluding that, although current CMR techniques have been successfully applied, novel methods such as mapping relaxation times may be preferred in the future. Dr. Andrew Arai discussed limitations of late enhancement (LGE) imaging in acute myocardial infarction, pointing out that the susceptibility of this technique to rapidly changing Gd kinetics in the salvaged area at risk during the first 5 to 7 minutes. In the discussion, the static approach of visualizing oedema by T2-weighted imaging was considered more robust. Dr. Ingo Eitel reported about the current published evidence on the clinical utility of imaging myocardial salvage by CMR. He focused on the validation of techniques by animal studies and comparative clinical data, concluding that the salvaged myocardium at risk is indeed a valid diagnostic target. Finally, Dr. Jan Bogaert addressed microvascular obstruction as another important prognostic marker in reperfused MI, which can be visualized by CMR and reported that comprehensive CMR scans including LV function, oedema, perfusion, necrosis and microvascular obstruction can be performed in little more than 30 minutes. In conclusion, the speakers agreed that CMR oedema imaging has an important role as an endpoint in clinical trials and will increasingly be used for clinical decision-making.
Myocardial oedema - a new diagnostic target?